Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver
- 31 October 2009
- journal article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 35 (10), 1092-1097
- https://doi.org/10.1016/j.ejso.2009.02.017
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survivalSurgery, 2007
- Gastroenteropancreatic endocrine tumors: clinical characterization before therapyNature Clinical Practice Endocrinology & Metabolism, 2007
- Surgical treatment of neuroendocrine metastases to the liver: : a plea for resection to increase survivalJournal of the American College of Surgeons, 2003
- Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: A 15-year single center prospective studySurgery, 2003
- MR Imaging of Hepatic Metastases Caused by Neuroendocrine Tumors: Comparing Four TechniquesAmerican Journal of Roentgenology, 2003
- Preoperative selective portal vein embolization before hepatectomy for liver metastases: Long-term results and impact on survivalSurgery, 2002
- Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumorsSurgery, 2001
- Hepatic neuroendocrine metastases: does intervention alter outcomes?Journal of the American College of Surgeons, 2000
- Isolated Liver Metastases from Neuroendocrine Tumors: Does Resection Prolong Survival?Journal of the American College of Surgeons, 1998
- Hepatic resection for metastatic neuroendocrine carcinomasThe American Journal of Surgery, 1995